Boston Immune Technologies & Therapeutics
Russell LaMontagne is the CEO at Boston Immune Technologies and Therapeutics. Previously, Russell was a Partner at Corinth Group.
Russell holds an MS from Yale University.
This person is not in any teams
This person is not in any offices